User contributions for MAlvis
A user with 1,244 edits. Account created on 17 July 2004.
6 February 2020
- 02:1002:10, 6 February 2020 diff hist +26 m User:MAlvis Added Theaflavin-3-gallate link current
16 November 2019
- 12:2612:26, 16 November 2019 diff hist +158 User:MAlvis No edit summary Tags: Mobile edit Mobile web edit
31 October 2019
- 13:2713:27, 31 October 2019 diff hist +254 User talk:Zefr →MEDRS tutorials for new medical editors
26 October 2019
- 22:5222:52, 26 October 2019 diff hist +257 Cholesterol →Cholesterol testing: added more recent links, many more recent advances in medical research easily found on Google in the last year.
- 22:4022:40, 26 October 2019 diff hist +1,010 Cholesterol →Cholesterol testing: Including more recent references continuing to confirm the long confirmed 1950 research.
21 October 2019
- 15:3515:35, 21 October 2019 diff hist +793 Cholesterol →Cholesterol testing: Clarifying discordant issues
12 April 2019
- 17:1017:10, 12 April 2019 diff hist +25 User:MAlvis Added Acyl-CoA and ACSL1
- 17:0817:08, 12 April 2019 diff hist −3 m ACSL1 →Clinical significance
- 17:0617:06, 12 April 2019 diff hist −3 m Acyl-CoA →Clinical Significance
- 17:0317:03, 12 April 2019 diff hist +525 Acyl-CoA Added a clinical significance section along with a recent research reference.
- 16:5816:58, 12 April 2019 diff hist +367 ACSL1 →Clinical significance: Added new role for gene in heart failure.
6 April 2019
- 18:0218:02, 6 April 2019 diff hist +75 MSD Ignition Created seperate links to the company website and their intro overview video
- 17:5617:56, 6 April 2019 diff hist −10 MSD Ignition No edit summary
- 17:5517:55, 6 April 2019 diff hist +47 MSD Ignition Added link to MSD overview by a rep of the MSD company in El Paso.
16 March 2019
- 15:3615:36, 16 March 2019 diff hist +351 Outline of diabetes →Low-carbohydrate dietary programs: Added research books and additional excellent references
8 February 2019
- 15:0715:07, 8 February 2019 diff hist +339 Oncotic pressure Worked to offer larger overview of an crucially important issue: distribution of extracellular water volumes, shifted such as in edema (extravascular) vs. intravascular depletion.
- 14:5714:57, 8 February 2019 diff hist +2 m Oncotic pressure No edit summary
- 14:5514:55, 8 February 2019 diff hist +129 Oncotic pressure Worked to improve the explanation and ability to understand what creates osmotic, oncotic pressure. Focusing on the molecules which do pass through semipermeable membranes, vs. the molecules which do not, explains the issue better.
- 14:4714:47, 8 February 2019 diff hist +17 Plasma protein Added link for oncotic pressure
7 February 2019
- 14:5214:52, 7 February 2019 diff hist +119 Beta cell Added that the Beta cells secrete both insulin and amylin in a fixed ration, both stimuli for to other cells to remove glucose from extracellular water, as able.
14 December 2018
- 19:1019:10, 14 December 2018 diff hist +102 Lipoprotein →Plasma lipoprotein particles: worked to improve wording accuracy and clarity
- 18:5718:57, 14 December 2018 diff hist +296 Cholesterol →Cholesterol testing: Corrected link and added a link to one (of many) research articles demonstrating discordance between lipid vs lipoproteins and outcome data.
- 18:4718:47, 14 December 2018 diff hist +323 Cholesterol →Cholesterol testing: Worked to more accurately define what both the lipid profile and what the acronyms HDL and LDL actually mean, along with their significance; not just the less clear terms good & bad.
- 18:2518:25, 14 December 2018 diff hist +28 Cholesterol →Physiology: Corrected error and added research reference.
- 18:2018:20, 14 December 2018 diff hist +65 Cholesterol →Function: Clarified that the polar group of both cholesterol and the phospholipid molecules interact with the surrounding water molecules, both with and outside the cell membranes, the fundamental hydrophilic versus hydrophobic organizational principles.
26 November 2018
- 16:5716:57, 26 November 2018 diff hist −1 m Apolipoprotein B →Role in lipoproteins and atherosclerosis
- 16:5416:54, 26 November 2018 diff hist +1,197 Apolipoprotein B Added an explanation of why cholesterol in NOT the correct issue. Particles which transport all lipids, including cholesterol, ARE the correct issue. I also added two research references to replace the previous objection "citation needed". Tag: Visual edit
- 16:1816:18, 26 November 2018 diff hist +65 Apolipoprotein B →Role in lipoproteins and atherosclerosis Tags: Mobile edit Mobile web edit
28 October 2018
- 22:1222:12, 28 October 2018 diff hist −12 Omega-3 fatty acid →Cardiovascular disease
- 22:1122:11, 28 October 2018 diff hist +187 Omega-3 fatty acid →Cardiovascular disease: added overview details of the Jelis & Improve-IT trials
- 22:0422:04, 28 October 2018 diff hist +1 m Omega-3 fatty acid →Cardiovascular disease
- 22:0422:04, 28 October 2018 diff hist +345 Omega-3 fatty acid →Cardiovascular disease: Added links to the Jelis and Reduce-IT Trial results verifying EPA supplementation benefits.
27 October 2018
- 16:3416:34, 27 October 2018 diff hist +460 Fat Broadened previously too narrow introduction paragraph which exclude other lipid molecules.
21 October 2018
- 20:0720:07, 21 October 2018 diff hist +43 Cholesterol Added a basic reason how animals differ from plants, which (with very rare exception) do not move rapidly on their own & animals can readily harvest and eat plants.
7 October 2018
- 18:4618:46, 7 October 2018 diff hist +533 User:MAlvis Added link to a more accurate illustration of atherosclerosis
- 18:4118:41, 7 October 2018 diff hist +32 User:MAlvis No edit summary
23 July 2018
- 03:5403:54, 23 July 2018 diff hist +2 Anti-obesity medication →Exenatide/liraglutide/semaglutide: added links and changed spelling of generic name to lower case
- 03:5303:53, 23 July 2018 diff hist +514 Anti-obesity medication Added an entry for pramlinatide, an analogue of Amylin, which is secreted by pancreas beta cells along with insulin release & activation, Added semaglutide to GlP-1 section.
- 03:4003:40, 23 July 2018 diff hist −144 Anti-obesity medication →Exenatide/Liraglutide: Pramlinatide is an analogue of Amylin, developed by Amylin Pharmaceuticals. It is not a GlP-1 analogue
8 June 2018
- 21:3321:33, 8 June 2018 diff hist +1,323 Therapeutic effect →Reducing complexity: Added some basics of water, also a single molecule, fundamental to living yet also potentially fatal.
22 December 2017
- 18:5518:55, 22 December 2017 diff hist 0 User talk:Jfdwolff No edit summary
- 18:5318:53, 22 December 2017 diff hist +3,224 User talk:Jfdwolff No edit summary
- 18:0818:08, 22 December 2017 diff hist +540 User talk:Jfdwolff Check out my Atherosclerosis page edits, time/ability permitting.
- 17:5317:53, 22 December 2017 diff hist +5,108 Atherosclerosis Worked to correct concept promoted within introduction that arteries narrow (long promoted based on angiography & assumptions) versus enlarge (based on actual more careful research) in response to atherosclerosis.
- 14:5314:53, 22 December 2017 diff hist +3 m Cholesterol No edit summary
13 December 2017
- 08:5008:50, 13 December 2017 diff hist +11 m Cholesterol More work on both improved wording & integration of relevant existing wikipedia articles
- 08:3908:39, 13 December 2017 diff hist +1 m Cholesterol No edit summary
- 08:3808:38, 13 December 2017 diff hist +90 Cholesterol Worked to clarify that cholesterol is an addition to phospholipid bilayers, as distinguised from only bilayers of phospholipids only
14 November 2017
- 21:2621:26, 14 November 2017 diff hist +40 m Lp-LpA2 No edit summary
- 21:2521:25, 14 November 2017 diff hist +42 m Lp-LpA2 Improved links
